Well-known Radiology Practice Investigated for Possible Medicare Fraud
All healthcare practices are susceptible to an audit, guilty or not. Make sure your radiology practice is prepared.
The Lindenhurst, N.Y. headquarters of Zwanger-Pesiri Radiology, a large, well-known practice, was raided by federal agents last week in response to allegations that the company was engaged in a multimillion-dollar Medicare fraud, according to an article in Newsday.
Agents from the Department of Health and Human Services’ Inspector General’s office, the FBI and Eastern District prosecutors are investigating allegations that the company vastly overbilled the federal Medicare program for its services. The company operates 12 medical offices in the Long Island, N.Y. area.
This recent event reiterates the importance of accurate reporting, as healthcare providers continue to face increasing threats of audits. Here are a couple links with stories we’ve done that could help practices that are concerned about an audit:
What Radiology Facilities Need to Know about Medicare Audits
Facing an Audit? Here’s What You Need to Know
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
